NEW YORK (GenomeWeb News) – Weill Cornell Medical College on Tuesday announced the creation of an institute that seeks to translate neuroscience research into treatment for patients.

The institute, Called the Feil Family Brain and Mind Research Institute, was created with a $28 million gift from the family of Gertrude and Louis Feil, benefactors of the college, and it will leverage advances in genomics, genetics, and other technologies to carry out its goal, Weill Cornell said.

The facility is expected to open at the end of 2013.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.